Skip to content

OptimizeRx OPRX Free cash flow yield

Free cash flow yield at other companies

Phreesia logo
PhreesiaPHR
13.6%+11.0pp
Doximity logo
DoximityDOCS
7.6%+5.1pp
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
24.7%+15.8pp
PubMatic logo
PubMaticPUBM
18%+7.5pp
National Research Corporation logo
National Research CorporationNRC
4.5%-0.6pp
Fluent, Inc. logo
Fluent, Inc.FLNT
-10.2%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

Based on trailing twelve months.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's free cash flow yield?
OptimizeRx (OPRX) reported free cash flow yield of 12.2% in Q1 2026.
How has OptimizeRx's free cash flow yield changed year-over-year?
OptimizeRx's free cash flow yield increased by 198.4% year-over-year, from 4.1% to 12.2%.
What is the long-term trend for OptimizeRx's free cash flow yield?
Over 3 years (2020 to 2025), OptimizeRx's free cash flow yield has grown at a 90.9% compound annual growth rate (CAGR), from -1.2% to 8.2%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.